Key result
Tetrahydropalmatine attenuated hyperlipidemia in high-fat diet-fed golden hamsters by reducing body weight, serum lipids, oxidative stress, and inhibiting the TLR4-NF-κB signaling pathway.
Why the study?
Whether tetrahydropalmatine regulates lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation in hyperlipidemia, along with its underlying protective mechanism, remains unclear.
Does Tetrahydropalmatine alleviate hyperlipidemia and associated metabolic/inflammatory changes in high-fat diet-fed golden hamsters?
Does Tetrahydropalmatine alleviate hyperlipidemia and associated metabolic/inflammatory changes in high-fat diet-fed golden hamsters?
Tetrahydropalmatine attenuates hyperlipidemia, hepatic steatosis, and inflammation in a high-fat diet hamster model by inhibiting the TLR4-NF-κB signaling pathway.
May support THP investigation in hyperlipidemia; animal data leaves open human translation.
Hyperlipidemia (HLP) is a lipid metabolism disorder that can induce a series of cardiovascular and cerebrovascular diseases, such as atherosclerosis, myocardial infarction, coronary heart disease, and stroke, which seriously threaten human health. Tetrahydropalmatine (THP) is a component of the plant Rhizoma corydalis and has been shown to exert hepatoprotective and anti-inflammatory effects in HLP. However, whether THP regulates lipid peroxidation in hyperlipidemia, endoplasmic reticulum (ER) stress and inflammasome activation and even the underlying protective mechanism against HLP remain unclear. An animal model of HLP was established by feeding a high-fat diet to golden hamsters. Our results showed that THP reduced the body weight and adipose index; decreased the serum content of ALT, AST, TC, TG, and LDL-C; decreased the free fatty acid hepatic lipid content (liver index, TC, TG, and free fatty acid); inhibited oxidative stress and lipid peroxidation; extenuated hepatic steatosis; and inhibited ER stress and inflammasome activation in high-fat diet-fed golden hamsters. In addition, for the first time, the potential mechanism by which THP protects against HLP through the TLR4-NF-κB signaling pathway was demonstrated. In conclusion, these data indicate that THP attenuates HLP through a variety of effects, including antioxidative stress, anti-ER stress, and anti-inflammatory effects. In addition, THP also inhibited the TLR4-NF-κB signaling pathway in golden hamsters.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2021) studied Hyperlipidemia. Tetrahydropalmatine (THP) was evaluated on Body weight, adipose index, serum lipids, oxidative stress, hepatic steatosis, ER stress, and inflammasome activation. Tetrahydropalmatine attenuated hyperlipidemia in high-fat diet-fed golden hamsters by reducing body weight, serum lipids, oxidative stress, and inhibiting the TLR4-NF-κB signaling pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: